BioRender-Icon

Adult female (stage II obesity)

Adult female (stage II obesity) - Editable icon of An adult female with stage II obesity, viewed from the anterior front side in anatomical position
[{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9c3/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9c3/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9c2/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9c2/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9c1/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9c1/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9c0/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9c0/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9bf/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9bf/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9be/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9be/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9bd/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9bd/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9bc/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9bc/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9bb/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9bb/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9ba/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9ba/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9b9/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9b9/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9b8/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9b8/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9b7/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9b7/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9b6/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9b6/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9b5/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9b5/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9b4/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9b4/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9b3/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9b3/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9b2/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9b2/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9b1/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9b1/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9b0/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9b0/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9af/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9af/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9ae/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9ae/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9ad/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9ad/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9ac/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9ac/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9ab/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9ab/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9aa/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9aa/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9a9/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9a9/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9a8/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9a8/63bd84ea2fab620022c3c7a6.png"}]
Dieses Icon verwenden – Kostenlos
Für die Registrierung ist keine Kreditkarte erforderlich.

Dieses Icon ist in BioRender vollständig bearbeitbar

  • Fügen Sie Text, Formen und weitere Icons hinzu
  • Durchsuchen Sie über 50.000 wissenschaftlich korrekte Icons
  • Jedes Icon, jede Linie und jedes Label lässt sich umfärben und neu anordnen
  • Exportieren oder teilen für jeden Anwendungszweck
Scientist Avatars

Schließen Sie sich über 4 Millionen Wissenschaftlern an, die bereits publikationsreife Abbildungen erstellen

Vom Icon zur fertigen Abbildung – in wenigen Minuten

  • Suche aus über 50.000 wissenschaftlich korrekten, von Experten begutachteten Icons
  • Anpassen mit Beschriftungen, Formen und zusätzlichen Icons – alles ist vollständig bearbeitbar
  • Exportieren oder teilen Sie Ihre Abbildungen mit Mitarbeitern
    ‍

Nicht ganz das richtige Icon? Entdecken Sie mehr.

Durchsuchen Sie über 50.000 Icons aus mehr als 30 lebenswissenschaftlichen Fachbereichen.

search icon
arrow-right
Schlagwörter
female obesity,obese female,obese woman,stage II obesity,stage 2 obesity,stage II,fat female,fat woman,overweight female,overweight woman,adult female,human body woman,person,body,people,figure,girl,face,eyes open,hair,overweight,body mass index,high BMI,BMI,fat,obesity,obese,chubby,large size,fatness,II,insulin,diabetes,hypertension,anterior,front,anatomical position,female obesity,obese female,obese woman,stage II obesity,stage 2 obesity
Mehr anzeigen

Versuchen Sie es mit einem Synonym oder registrieren Sie sich, um ein Icon über die App anzufordern.

Bildtypen

Adult female (stage II obesity) icon JPEG

Adult female (stage II obesity) icon PNG

Adult female (stage II obesity) icon SVG

Adult female (stage II obesity) icon GIF

Häufig gestellte Fragen zu BioRender-Icons

How are scientists using the Adult female (stage II obesity) icon in their work?

BioRender users often use the Adult female (stage II obesity) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Human Anatomy.

Kann ich dieses Icon in einer BioRender-Abbildung oder wissenschaftlichen Illustration verwenden?

Yes, the Adult female (stage II obesity) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Adult female (stage II obesity) icon customizable in BioRender?

Most icons in BioRender, including the Adult female (stage II obesity) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Adult female (stage II obesity) icon for publication or presentations?

Yes, figures containing the Adult female (stage II obesity) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Adult female (stage II obesity) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Adult female (stage II obesity) icon — especially those focused on Human Anatomy. You can search BioRender’s template library or add this icon manually to any canvas.

Was ist BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Adult female (stage II obesity) icon along with our library of more than 30,000 life science icons.

Dieses Icon in BioRender verwenden

Erstellen Sie noch heute professionelle wissenschaftliche Abbildungen
antibody elements3D Phospholipid illustration

Suchen Sie nach wissenschaftlichen Inhalten?

Durchsuchen Sie über 50.000 Icons und Vorlagen, die von Fachkollegen geprüft, einfach zu verwenden und kostenlos sind.

Finden Sie jetzt das Passende
x icon